Indication
Metastatic malignant melanoma
Metastatic malignant melanoma is an advanced, highly aggressive form of cancer arising from transformed melanocytes, typically originating in the skin but occasionally in mucosal membranes or the uvea. Read more about Metastatic malignant melanoma
15 drugs 12 manufacturers
Drugs that treat it
Common Metastatic malignant melanoma therapies.
AMTAGVI (lifileucel)
DACARBAZINE
PROLEUKIN (aldesleukin)
DACARBAZINE
DACARBAZINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMetastatic malignant melanoma is an advanced, highly aggressive form of cancer arising from transformed melanocytes, typically originating in the skin but occasionally in mucosal membranes or the uvea.
It is pathophysiologically characterized by the hematogenous and lymphatic dissemination of malignant cells beyond regional lymph nodes into distant anatomical sites, most commonly the lungs, liver, brain, bones, distant subcutaneous tissues, and nonregional lymph nodes.
Patients with stage IV disease frequently present with systemic symptoms, organ-specific dysfunctions corresponding to metastatic foci, elevated serum lactate dehydrogenase levels, and oncogenic driver alterations such as BRAF mutations.
- nih.gov
Metastatic malignant melanoma is an advanced, highly aggressive form of cancer arising from transformed melanocytes, typically originating in the skin but occasionally in mucosal membranes or the uvea
- nih.gov
Metastatic malignant melanoma is an advanced, highly aggressive form of cancer arising from transformed melanocytes, typically originating in the skin but occasionally in mucosal membranes or the uvea
- nih.gov
It is pathophysiologically characterized by the hematogenous and lymphatic dissemination of malignant cells beyond regional lymph nodes into distant anatomical sites, most commonly the lungs, liver, brain, bones, distant subcutaneous tissues, and nonregional lymph nodes
- nih.gov
It is pathophysiologically characterized by the hematogenous and lymphatic dissemination of malignant cells beyond regional lymph nodes into distant anatomical sites, most commonly the lungs, liver, brain, bones, distant subcutaneous tissues, and nonregional lymph nodes
- cancer.gov
It is pathophysiologically characterized by the hematogenous and lymphatic dissemination of malignant cells beyond regional lymph nodes into distant anatomical sites, most commonly the lungs, liver, brain, bones, distant subcutaneous tissues, and nonregional lymph nodes
- mountsinai.org
Patients with stage IV disease frequently present with systemic symptoms, organ-specific dysfunctions corresponding to metastatic foci, elevated serum lactate dehydrogenase levels, and oncogenic driver alterations such as BRAF mutations
- pennmedicine.org
Patients with stage IV disease frequently present with systemic symptoms, organ-specific dysfunctions corresponding to metastatic foci, elevated serum lactate dehydrogenase levels, and oncogenic driver alterations such as BRAF mutations
Personalize your experience
Follow Metastatic malignant melanoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.